The GARP complex is required for cellular sphingolipid homeostasis

Area of Science:

• Cell Biology
• Molecular Biology
• Neuroscience

Background:

• Sphingolipids are crucial membrane components and signaling molecules in eukaryotic cells.
• Their precise regulation of levels and localization is essential but mechanistically unclear.
• Dysregulation of sphingolipid metabolism is implicated in various cellular dysfunctions.

Purpose of the Study:

• To identify key regulators of sphingolipid homeostasis.
• To investigate the role of the Golgi-associated retrograde protein (GARP) complex in sphingolipid metabolism.
• To explore the mechanistic link between GARP function and diseases like progressive cerebello-cerebral atrophy type 2 (PCCA2).

Main Methods:

• Utilized yeast and mammalian cell models to study GARP complex function.
• Analyzed sphingolipid synthesis intermediates and sterol distribution.
• Investigated lysosomal function and cellular phenotypes in GARP-deficient cells.
• Modeled a human disease mutation (VPS53 allele in PCCA2) in yeast.

Main Results:

• Identified the GARP complex as essential for maintaining sphingolipid homeostasis.
• GARP deficiency resulted in accumulation of sphingolipid synthesis intermediates and altered sterol distribution.
• Lysosomal dysfunction was observed in GARP-deficient cells.
• A yeast model mimicking a PCCA2-associated mutation showed similar, though less severe, cellular defects.

Conclusions:

• The GARP complex plays a critical role in cellular sphingolipid homeostasis.
• GARP dysfunction contributes to cellular pathologies relevant to PCCA2.
• Inhibiting de novo sphingolipid synthesis can ameliorate GARP-deficiency-related cellular defects, suggesting a therapeutic avenue for PCCA2.